FDA Adverse Event Malfunction Summary report: N

ENDOTAK RELIANCE

MDR report key: 3053136 · Received April 11, 2013

Report

Report Number
2124215-2013-04596
Event Type
Malfunction
Date Received
April 11, 2013
Date of Event
March 10, 2013
Report Date
January 12, 2014
Manufacturer
CPI - DEL CARIBE
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE LOCAL AREA SALES REPRESENTATIVE WAS CONTACTED FOR ADDITIONAL INFORMATION. AT THIS TIME, NO FURTHER INFORMATION IS AVAILABLE AND RECORDS INDICATE THESE PRODUCTS REMAIN IN SERVICE. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE THIS REPORT WILL BE UPDATED.

Additional Manufacturer Narrative · 1

THE LOCAL AREA FIELD REPRESENTATIVE WAS CONTACTED FOR ADDITIONAL INFORMATION. AT THIS TIME, NO FURTHER INFORMATION IS AVAILABLE AND RECORDS INDICATE THIS SYSTEM REMAINS IN SERVICE. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE THIS REPORT WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE DEFIBRILLATION LEAD AND CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) EXHIBITED A HIGH OUT OF RANGE SHOCK IMPEDANCE MEASUREMENT. REVIEW OF DAILY MEASUREMENTS SHOWED THE SHOCK IMPEDANCE MEASUREMENTS HAVE BEEN BETWEEN 90 AND 110 OHMS. ALL OTHER LEAD MEASUREMENTS WERE STABLE. A HEALTH CARE PROFESSIONAL (HCP) PLANNED TO SCHEDULE THE PATIENT FOR FURTHER EVALUATION. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED INDICATING THIS DEVICE AND LEAD CONTINUE TO EXHIBIT HIGH SHOCK IMPEDANCE MEASUREMENTS, INCLUDING OUT OF RANGE MEASUREMENTS. TECHNICAL SERVICES DISCUSSED THE PROGRAMMED SHOCKING VECTOR COULD RETURN HIGH SHOCK IMPEDANCE MEASUREMENTS. A HEALTH CARE PROFESSIONAL (HCP) PLANNED TO SCHEDULE THE PATIENT FOR FURTHER EVALUATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
155043 ENDOTAK RELIANCE IMPLANTABLE LEAD LWS CPI - DEL CARIBE 0185

Patients

Seq Age Sex Outcome Treatment
1 64 YR 4592| N119| 0185| 4470